Causes of death in hospitalized patients with systemic lupus erythematosus: a 10-year multicenter nationwide Chinese cohort.


Journal

Clinical rheumatology
ISSN: 1434-9949
Titre abrégé: Clin Rheumatol
Pays: Germany
ID NLM: 8211469

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 16 10 2017
accepted: 08 08 2018
revised: 28 05 2018
pubmed: 21 8 2018
medline: 14 5 2019
entrez: 21 8 2018
Statut: ppublish

Résumé

To estimate the mortality and describe the causes of death in a large multicenter cohort of hospitalized patients with SLE in China. This was a retrospective study of a nationwide SLE cohort (10 centers, 29,510 hospitalized patients) from 2005 to 2014 in China. Standardized mortality ratios (SMRs) were calculated for all death and were stratified by sex and age. Chi-square test was used to determine whether the major causes of death vary in age, sex, duration of SLE, disease activity, or medications. Comparison between dead patients and survival controls was used to identify the risk factors for mortality. Logistic regression analysis was used to evaluate the risk factors for mortality. A total of 360 patients died during the study period, accounting for 1.22%. The overall SMR was 2.13 (95% CI 1.96, 2.30), with a particularly high SMR seen in subgroups characterized by younger age. Infection (65.8%) was the most common cause of death, followed by lupus nephritis (48.6%), hematological abnormality (18.1%), neuropsychiatric lupus/NPSLE (15.8%), and interstitial pneumonia (13.1%). Cardiovascular disease and malignancy contributed little to the causes of death. Infection, in particular severe pulmonary infection, emerged as the foremost risk factor for mortality, followed by lupus encephalopathy. However, lupus nephritis and hematological abnormalities occurred more frequently in survival patients. SLE patients at a younger age of diagnosis have a poorer prognosis. Infection dominated the causes of death in recent China. Ethnicity and medications might account for the differences in causes of death compared with western populations.

Identifiants

pubmed: 30123930
doi: 10.1007/s10067-018-4259-z
pii: 10.1007/s10067-018-4259-z
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

107-115

Subventions

Organisme : National Natural Science Foundation of China
ID : 81373211
Organisme : National Natural Science Foundation of China
ID : 81502016

Références

Ann Rheum Dis. 2002 May;61(5):409-13
pubmed: 11959764
Am J Med. 1976 Feb;60(2):221-5
pubmed: 1251849
Rheumatology (Oxford). 2003 Sep;42(9):1122-3
pubmed: 12923275
Medicine (Baltimore). 2003 Sep;82(5):299-308
pubmed: 14530779
Autoimmun Rev. 2004 Aug;3(6):423-53
pubmed: 15351310
Arthritis Rheum. 1992 Jun;35(6):630-40
pubmed: 1599520
Medicine (Baltimore). 2005 Jul;84(4):218-24
pubmed: 16010206
Arthritis Rheum. 2006 Aug;54(8):2550-7
pubmed: 16868977
Am J Med. 2006 Aug;119(8):700-6
pubmed: 16887417
Arthritis Rheum. 2011 May;63(5):1182-9
pubmed: 21391198
J Rheumatol. 2011 Jul;38(7):1289-95
pubmed: 21459949
Lupus. 2011 Aug;20(9):989-97
pubmed: 21700655
Arthritis Care Res (Hoboken). 2012 Feb;64(2):159-68
pubmed: 22052624
Heart. 2012 Aug;98(16):1207-12
pubmed: 22826558
Arthritis Rheum. 1990 Jan;33(1):37-48
pubmed: 2302266
Cochrane Database Syst Rev. 2012 Dec 12;12:CD002922
pubmed: 23235592
Clin Rheumatol. 2014 Jan;33(1):57-63
pubmed: 24046218
Lupus. 2013 Oct;22(12):1286-94
pubmed: 24098001
Arthritis Care Res (Hoboken). 2014 Apr;66(4):608-16
pubmed: 24106157
Autoimmunity. 2014 Mar;47(2):67-76
pubmed: 24228980
Clin Rheumatol. 2014 Jul;33(7):947-53
pubmed: 24794488
Lupus. 2014 Dec;23(14):1546-52
pubmed: 25209070
Rheumatology (Oxford). 2015 May;54(5):836-43
pubmed: 25323056
Medicine (Baltimore). 2015 May;94(17):e794
pubmed: 25929930
Rheumatology (Oxford). 2016 May;55(5):854-60
pubmed: 26748350
Curr Rheumatol Rep. 2016 Apr;18(4):21
pubmed: 26984805
Eur Heart J. 2016 Nov 7;37(42):3232-3245
pubmed: 27523477
PLoS One. 2016 Dec 28;11(12):e0168619
pubmed: 28030595
Eur Heart J Suppl. 2016 May;18(Suppl F):F2-F11
pubmed: 28533724
JAMA. 1974 Mar 25;227(12):1399-402
pubmed: 4406022
Arthritis Rheum. 1982 Nov;25(11):1271-7
pubmed: 7138600
JAMA. 1981 Mar 6;245(9):934-8
pubmed: 7463697
Arthritis Rheum. 1995 Oct;38(10):1492-9
pubmed: 7575699
Arthritis Rheum. 1997 Sep;40(9):1725
pubmed: 9324032
Arthritis Rheum. 1999 Jan;42(1):46-50
pubmed: 9920013

Auteurs

Xin-Yao Wu (XY)

Department of Rheumatology and Immunology, Shanghai Jiao Tong University School of Medicine Affiliated Ruijin Hospital, No. 197 Ruijin Second Road, Huangpu District, Shanghai, 200025, China.

Min Yang (M)

Department of Rheumatology and Immunology, Sichuan University West China Hospital, Chengdu, China.

Yue-Sheng Xie (YS)

Department of Rheumatology and Immunology, Guangdong General Hospital, Guangzhou, China.

Wei-Guo Xiao (WG)

Department of Rheumatology and Immunology, The First Hospital Affiliated to China Medical University, Shenyang, China.

Jin Lin (J)

Department of Rheumatology and Immunology, Zhejiang University School of Medicine First Affiliated Hospital, Hangzhou, China.

Bin Zhou (B)

Department of Rheumatology and Immunology, Sichuan People's Hospital, Chengdu, China.

Xin Guan (X)

Department of Rheumatology and Immunology, Second Xiangya Hospital, Changsha, China.

Cai-Nan Luo (CN)

Department of Rheumatology and Immunology, Xinjiang Uygur People's Hospital, No. 91 Tianchi Road, Tianshan District, Urumqi, 830001, Xinjiang Uygur Autonomous Region, China.

Nan Che (N)

Department of Rheumatology and Immunology, Jiangsu People's Hospital, Nanjing, China.

Xing-Zhen Liu (XZ)

Department of Rheumatology and Immunology, Changhai Hospital, Shanghai, China.

Chao Wang (C)

Beijing Institute of Traumatology and Orthopaedics, Beijing Jishuitan Hospital, Fourth Clinical Medical College, Peking University, Beijing, China.

Jia-Lin Teng (JL)

Department of Rheumatology and Immunology, Shanghai Jiao Tong University School of Medicine Affiliated Ruijin Hospital, No. 197 Ruijin Second Road, Huangpu District, Shanghai, 200025, China.

Xiao-Bing Cheng (XB)

Department of Rheumatology and Immunology, Shanghai Jiao Tong University School of Medicine Affiliated Ruijin Hospital, No. 197 Ruijin Second Road, Huangpu District, Shanghai, 200025, China.

Jun-Na Ye (JN)

Department of Rheumatology and Immunology, Shanghai Jiao Tong University School of Medicine Affiliated Ruijin Hospital, No. 197 Ruijin Second Road, Huangpu District, Shanghai, 200025, China.

Yu-Tong Su (YT)

Department of Rheumatology and Immunology, Shanghai Jiao Tong University School of Medicine Affiliated Ruijin Hospital, No. 197 Ruijin Second Road, Huangpu District, Shanghai, 200025, China.

Hui Shi (H)

Department of Rheumatology and Immunology, Shanghai Jiao Tong University School of Medicine Affiliated Ruijin Hospital, No. 197 Ruijin Second Road, Huangpu District, Shanghai, 200025, China.

Yu-Feng Yin (YF)

Department of Rheumatology and Immunology, Shanghai Jiao Tong University School of Medicine Affiliated Ruijin Hospital, No. 197 Ruijin Second Road, Huangpu District, Shanghai, 200025, China.

Meng-Ru Liu (MR)

Department of Rheumatology and Immunology, Shanghai Jiao Tong University School of Medicine Affiliated Ruijin Hospital, No. 197 Ruijin Second Road, Huangpu District, Shanghai, 200025, China.

Yue Sun (Y)

Department of Rheumatology and Immunology, Shanghai Jiao Tong University School of Medicine Affiliated Ruijin Hospital, No. 197 Ruijin Second Road, Huangpu District, Shanghai, 200025, China.

Qiong-Yi Hu (QY)

Department of Rheumatology and Immunology, Shanghai Jiao Tong University School of Medicine Affiliated Ruijin Hospital, No. 197 Ruijin Second Road, Huangpu District, Shanghai, 200025, China.

Zhuo-Chao Zhou (ZC)

Department of Rheumatology and Immunology, Shanghai Jiao Tong University School of Medicine Affiliated Ruijin Hospital, No. 197 Ruijin Second Road, Huangpu District, Shanghai, 200025, China.

Hui-Hui Chi (HH)

Department of Rheumatology and Immunology, Shanghai Jiao Tong University School of Medicine Affiliated Ruijin Hospital, No. 197 Ruijin Second Road, Huangpu District, Shanghai, 200025, China.

Yi Liu (Y)

Department of Rheumatology and Immunology, Sichuan University West China Hospital, Chengdu, China.

Xiao Zhang (X)

Department of Rheumatology and Immunology, Guangdong General Hospital, Guangzhou, China.

Jin-Wei Chen (JW)

Department of Rheumatology and Immunology, Second Xiangya Hospital, Changsha, China.

Miao-Jia Zhang (MJ)

Department of Rheumatology and Immunology, Jiangsu People's Hospital, Nanjing, China.

Dong-Bao Zhao (DB)

Department of Rheumatology and Immunology, Changhai Hospital, Shanghai, China.

Cheng-de Yang (CD)

Department of Rheumatology and Immunology, Shanghai Jiao Tong University School of Medicine Affiliated Ruijin Hospital, No. 197 Ruijin Second Road, Huangpu District, Shanghai, 200025, China. yangchengde@sina.com.

Li-Jun Wu (LJ)

Department of Rheumatology and Immunology, Xinjiang Uygur People's Hospital, No. 91 Tianchi Road, Tianshan District, Urumqi, 830001, Xinjiang Uygur Autonomous Region, China. wwlj330@126.com.

Hong-Lei Liu (HL)

Department of Rheumatology and Immunology, Shanghai Jiao Tong University School of Medicine Affiliated Ruijin Hospital, No. 197 Ruijin Second Road, Huangpu District, Shanghai, 200025, China. hong-lei-liu@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH